Prospective Observational Study to Establish Predictors of Glyburide Success in Women with Gestational Diabetes Mellitus
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective To establish parameters associated with therapeutic success in gestational diabetics treated with glyburide.Study design A total of 69 gestational diabetics who failed dietary therapy were treated with glyburide. Inadequate glycemic control on maximum dose glyburide (10 mg b.i.d.) was considered treatment failure. The glyburide failure rate was calculated and factors that might predict success with glyburide were analyzed between the success and failure groups using chi(2) or Student'st-tests.Results The glyburide failure rate was 18.8%. Gestational age at glyburide initiation (p<0.01), pretreatment fasting blood sugars (p<0.001), and 1-hour postprandial values (p<0.001) were the only statistically significant factors between the two groups. Glyburide success was predicted if dietary failure occurred after 30 weeks, or fasting blood sugars were <110 mg/dl and 1-hour postprandials were <140 mg/dl (sensitivity 98%, specificity 65%).Conclusion Gestational diabetics who fail dietary therapy after 30 weeks gestation or have fasting blood sugars <110 mg/dl and 1-hour postprandials <140 mg/dl do well on glyburide therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
ACOG Practice Bulletin No. 30: Gestational Diabetes
(2001) · Obstetrics & Gynecology · doi:10.1097/00006250-200109000-00037 · Cited by 301
RetractedCriteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 8×
“However, 18% of patients in that study who received glyburide were outside the desired range of glycemic control.(7) The majority of these 18% were managed without insulin, although Langer does not state why.”
BackgroundMethodResultInfluentialWeiss, P. (1988) · Cited by 780
Insignificant transfer of glyburide occurs across the human placenta
Elliott, B. D., Langer, O., Schenker, S., & Johnson, R. F. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90421-m · Cited by 260
Elliott, B. D., Schenker, S., Langer, O., Johnson, R., & Prihoda, T. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90078-7 · Cited by 250
Neonatal Hypoglycaemia in Infants of Diabetic Mothers given Sulphonylurea Drugs in Pregnancy
Kemball, M. L., McIver, C., Milner, R. D. G., Nourse, C. H., Schiff, D., & Tiernan, J. R. (1970) · Archives of Disease in Childhood · doi:10.1136/adc.45.243.696 · Cited by 94 · cited 1×
“Oral hypoglycemic agents, utilized extensively in the nonpregnant population, have not been recommended in pregnancy due to their potentially adverse fetal effects”
BackgroundProlonged Symptomatic Neonatal Hypoglycemia Associated with Maternal Chlorpropamide Therapy
Zucker, P., & Simon, G. (1968) · Pediatrics · doi:10.1542/peds.42.5.824 · Cited by 80
Hypoglycemia in newborn infants of normal and diabetic mothers.
Farquhar, J. W., & Isles, T. E. (1968) · PubMed · Cited by 28
Cited by
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
“Compared with insulin, glyburide may be more convenient, is less expensive (184), does not require intensive educational instruction at initiation of therapy, and is preferred by most patients (179, 183).”
Thompson, D., Berger, H., Feig, D., Gagnon, R., Kader, T., Keely, E., Kozak, S., Ryan, E., Sermer, M., & Vinokuroff, C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.044 · Cited by 377
Practice Bulletin No. 180: gestational diabetes mellitus.
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002159 · Cited by 324
Endocrine Disorders in Pregnancy
Ramos, G. A., & Moore, T. R. (2012) · Avery's Diseases of the Newborn · doi:10.1016/b978-1-4377-0134-0.10009-5 · Cited by 267
Self-citationHebert, M., Ma, X., Naraharisetti, S., Krudys, K., Umans, J., Hankins, G., Caritis, S., Miodovnik, M., Mattison, D., Unadkat, J., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.5 · Cited by 252
Alfadhli, E. M. (2015) · Saudi Medical Journal · doi:10.15537/smj.2015.4.10307 · Cited by 245
Jacobson, G. F., Ramos, G. A., Ching, J. Y., Kirby, R. S., Ferrara, A., & Field, D. R. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.03.018 · Cited by 177
Nicholson, W., Bolen, S., Witkop, C. T., Neale, D., Wilson, L., & Bass, E. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318190a459 · Cited by 161
Management of Diabetes in Pregnancy
Ballas, J., Moore, T. R., & Ramos, G. A. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0249-0 · Cited by 149
Self-citationCamelo Castillo, W., Boggess, K., Stürmer, T., Brookhart, M. A., Benjamin, D. K., & Jonsson Funk, M. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000285 · Cited by 118
Perspectives in Gestational Diabetes Mellitus: A Review of Screening,Diagnosis, and Treatment
Perkins, J. M., Dunn, J. P., & Jagasia, S. M. (2007) · Clinical Diabetes · doi:10.2337/diaclin.25.2.57 · Cited by 118
The management of gestational diabetes
Cheung, W. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3405 · Cited by 110
Perfusion studies of glyburide transfer across the human placenta: Implications for fetal safety
Kraemer, J. M., Klein, J., Lubetsky, A., & Koren, G. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.12.005 · Cited by 117
Lain, K. Y., Garabedian, M. J., Daftary, A., & Jeyabalan, A. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.02.038 · Cited by 100
Safety of Glyburide for Gestational Diabetes: A Meta-Analysis of Pregnancy Outcomes
Moretti, M. E., Rezvani, M., & Koren, G. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1k577 · Cited by 97
Management of Gestational Diabetes: Pharmacologic Treatment Options and Glycemic Control
Langer, O. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.09.007 · Cited by 96
“Kremer, 2004 [95] Prosp, observ Macrosomia: 19% Chmait, 2004 [96] Prosp, observ Caesarean section: 36% Macrosomia: 7% 6 4”
A review of current treatment strategies for gestational diabetes mellitus
Kelley, K., Carroll, D., & Meyer, A. (2015) · Drugs in Context · doi:10.7573/dic.212282 · Cited by 88
Predictors of glyburide failure in the treatment of gestational diabetes
Kahn, B. F., Davies, J. K., Lynch, A. M., Reynolds, R. M., & Barbour, L. A. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000218704.28313.36 · Cited by 85
Rochon, M., Rand, L., Roth, L., & Gaddipati, S. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.07.029 · Cited by 82
The use of glyburide in the management of gestational diabetes mellitus: A meta-analysis
Zeng, Y.-C., Li, M.-J., Chen, Y., Jiang, L., Wang, S.-M., Mo, X.-L., & Li, B.-Y. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2014.03.001 · Cited by 76
Comparison of Glyburide versus Insulin in Management of Gestational Diabetes Mellitus
Ogunyemi, D. A., Jesse, M., & Davidson, M. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.427 · Cited by 74
Oral Antidiabetic Agents in Pregnancy and Lactation: A Paradigm Shift?
Feig, D. S., Briggs, G. G., & Koren, G. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k045 · Cited by 73
Auryan, S., & Itamar, R. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00896.x · Cited by 72
Gestational diabetes mellitus: challenges in diagnosis and management
Mpondo, B. C. T., Ernest, A. I., & Dee, H. E. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0169-7 · Cited by 86
“Regarding glyburide therapy, certain factors are associated with higher rates of success, including initiation after 30 weeks gestation or fasting blood glucose levels <110 mg/dl and 1-h postprandial glucose levels <140 mg/dl [47].”
BackgroundGestational diabetes mellitus management with oral hypoglycemic agents
Ryu, R. J., Hays, K. E., & Hebert, M. F. (2014) · Seminars in Perinatology · doi:10.1053/j.semperi.2014.08.012 · Cited by 59
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
Waugh, N., Royle, P., Clar, C., Henderson, R., Cummins, E., Hadden, D., Lindsay, R., & Pearson, D. (2010) · Health Technology Assessment · doi:10.3310/hta14450 · Cited by 60
Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus
Malek, R., & Davis, S. N. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1187131 · Cited by 54
“Another study attempting to answer the same question investigated 69 women with gestational diabetes and found that women who succeeded with glyburide therapy did not fail dietary therapy until after 30 weeks of gestation, had fasting sugars <110 mg/dL, and 1-h postprandial <140 mg/dL (sensitivity 98% and specificity…”
BackgroundThe use of oral hypoglycaemic agents in pregnancy
Holt, R. I. G., & Lambert, K. D. (2014) · Diabetic Medicine · doi:10.1111/dme.12376 · Cited by 50
Pregnancy outcomes in women with an early diagnosis of gestational diabetes mellitus
Feghali, M. N., Abebe, K. Z., Comer, D. M., Caritis, S., Catov, J. M., & Scifres, C. M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.004 · Cited by 50
Gestational diabetes: diagnosis and management
Cheng, Y. W., & Caughey, A. B. (2008) · Journal of Perinatology · doi:10.1038/jp.2008.62 · Cited by 52
Ramos, G. A., Jacobson, G. F., Kirby, R. S., Ching, J. Y., & Field, D. R. (2007) · Journal of Perinatology · doi:10.1038/sj.jp.7211683 · Cited by 44
Glibenclamida no tratamento do diabete melito gestacional em estudo comparado à insulina
Silva, J. C., Bertini, A. M., Taborda, W., Becker, F., Bebber, F. R. L., Aquim, G. M. D. C., & Viesi, J. M. Z. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000400007 · Cited by 42
“De forma contrária, alguns autores apontaram maior incidência de macrossomia (41%) no grupo da insulina (6,18), e menor em seu grupo tratado com a medicação oral (27%), ambas incidências maiores que a encontrada em nosso estudo no grupo da glibenclamida (15,62%) e em outros estudos com valores semelhantes ao nosso (18…”
BackgroundGlyburide for the Treatment of Gestational Diabetes
Moore, T. R. (2007) · Diabetes Care · doi:10.2337/dc07-s218 · Cited by 53
Self-citationOral hypoglycemic agents for gestational diabetes mellitus?
Maymone, A. C., Baillargeon, J.-P., Ménard, J., & Ardilouze, J.-L. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.521740 · Cited by 41
“For glyburide, aside from the Langer study [5] (4% failure), two small retrospective studies (n = 95 and 69) among Hispanic women revealed that the respective 19 and 21% failure rates were related to maternal age, early diagnosis (< 25 weeks), multiparity and higher fasting glucose levels, suggesting that many of thes…”
BackgroundResultPrecision gestational diabetes treatment: a systematic review and meta-analyses
Benham, J. L., Gingras, V., Mclennan, N., Most, J., Yamamoto, J. M., Aiken, C., Ozanne, S. E., Reynolds, R. M., PMDI, A., Tobias, D. K., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00371-0 · Cited by 54
Insulins and oral hypoglycemic agents in pregnancy
Homko, C. J., & Reece, E. A. (2006) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050600863376 · Cited by 46
“Chmait and colleagues [48] reported a similar success rate (81.”
ResultSingh, S. K., & Rastogi, A. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2008.04.007 · Cited by 54
Diabetes Mellitus Complicating Pregnancy
Landon, M. B., Catalano, P. M., & Gabbe, S. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06930-7.50039-6 · Cited by 36
Oral Agents for the Management of Gestational Diabetes
Berggren, E. K., & Boggess, K. (2013) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3182a8e0a5 · Cited by 30
Therapeutic management of gestational diabetes
Jacqueminet, S., & Jannot-Lamotte, M.-F. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.016 · Cited by 36
Pharmacological Management of Gestational Diabetes Mellitus
Mukerji, G., & Feig, D. S. (2017) · Drugs · doi:10.1007/s40265-017-0807-0 · Cited by 41
“1 mmol/L)) on the OGTT or pharmacological therapy was needed at an early gestational age [85, 86].”
BackgroundMirzamoradi, M., Heidar, Z., Faalpoor, Z., Naeiji, Z., & Jamali, R. (2015) · PubMed · Cited by 35
Efficacy of metformin versus insulin in the management of pregnancy with diabetes.
Waheed, S., Malik, F. P., & Mazhar, S. B. (2013) · PubMed · Cited by 30
Glyburide in gestational diabetes—prediction of treatment failure
Yogev, Y., Melamed, N., Chen, R., Nassie, D., Pardo, J., & Hod, M. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2010.531323 · Cited by 25
“One of the major potential drawback of using glyburide as the first-line of medical treatment in GDM is the concern that women who will eventually fail glyburide therapy may be suboptimally controlled for several weeks until treatment is switched to insulin [4,9].”
BackgroundResultInfluentialGlyburide: The new alternative for treating gestational diabetes?
Durnwald, C. P., & Landon, M. B. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.03.019 · Cited by 27
“Several smaller studies have reported success in achieving good glycemic control with glyburide, but with slightly higher failure rates.(2-4) A recent American College”
ResultOral Anti-Hyperglycemic Agents for the Management of Gestational Diabetes Mellitus
Langer, O. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.03.004 · Cited by 28
The effectiveness of glibenclamide in women with gestational diabetes
Holt, R. I. G., Clarke, P., Parry, E. C., & Coleman, M. A. G. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00828.x · Cited by 25
Pharmacotherapy for gestational diabetes
Patti, A. M., Giglio, R. V., Pafili, K., Rizzo, M., & Papanas, N. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1509955 · Cited by 19
Glyburide for the treatment of gestational diabetes mellitus.
Kimber-Trojnar, Ż., Marciniak, B., Leszczyńska‐Gorzelak, B., Trojnar, M. P., & Oleszczuk, J. (2008) · PubMed · Cited by 21
Is Glyburide Safe in Pregnancy?
Kimber-Trojnar, Ż., Marciniak, B., Patro-Małysza, J., Skórzyńska-Dziduszko, K., Poniedziałek‐Czajkowska, E., Mierzyński, R., Gałczyński, K., Trojnar, M. P., Leszczyńska‐Gorzelak, B., & Oleszczuk, J. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140330200254 · Cited by 20
“These studies included randomized prospective trials [11, 76, 93-98], prospective observational studies [16, 99-106], and retrospective studies [107-114], and show that glyburide seems unlikely to negatively influence the fetus [60, 115-117].”
BackgroundShuster, D. L., Shireman, L. M., Ma, X., Shen, D. D., Flood-Nichols, S. K., Ahmed, M. S., Clark, S. M., Caritis, S. N., Venkataramanan, R., Haas, D. M., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1749 · Cited by 20
Diabetes Mellitus Complicating Pregnancy
Landon, M. B., Catalano, P. M., & Gabbe, S. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1935-2.00039-9 · Cited by 23
Bowker, S. L., Savu, A., Yeung, R. O., Johnson, J. A., Ryan, E. A., & Kaul, P. (2017) · Diabetic Medicine · doi:10.1111/dme.13394 · Cited by 17
Theodoraki, A., & Baldeweg, S. E. (2008) · British Journal of Hospital Medicine · doi:10.12968/hmed.2008.69.10.31315 · Cited by 19
Lassi, Z. S., & Bhutta, Z. A. (2013) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2013.841453 · Cited by 16
Gestational Diabetes Mellitus: A Pill or a Shot?
Saade, G. R. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000156724.09130.fe · Cited by 16
“In clinical practice, “glyburide failure” may be more common in womenwith high fasting blood concentrations of glucose ( 110 mg/dL) or with earlier need for pharmacologic therapy.(9,10) This may be due to inclusion of some women who probably have more than just GDM or due to inappropriate dosing of glyburide.”
BackgroundNovel therapies for diabetes mellitus in pregnancy
Feghali, M. N., & Scifres, C. (2018) · BMJ · doi:10.1136/bmj.k2034 · Cited by 17
Helal, K. F., Badr, M. S., Rafeek, M. E.-S., Elnagar, W. M., & Lashin, M. E.-B. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05430-3 · Cited by 17
Counterpoint: Oral Hypoglyemic Agents Should Be Used to Treat Diabetic Pregnant Women
Coetzee, E. J. (2007) · Diabetes Care · doi:10.2337/dc07-1620 · Cited by 17
Pharmacological Management of Gestational Diabetes Mellitus
Bergel, R., Hadar, E., Toledano, Y., & Hod, M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0802-y · Cited by 19
Drugs to Control Diabetes During Pregnancy
Feghali, M. N., Umans, J. G., & Catalano, P. M. (2019) · Clinics in Perinatology · doi:10.1016/j.clp.2019.02.005 · Cited by 16
Quinze questions pratiques concernant le diabète gestationnel
Clay, J.-C., Deruelle, P., Fischer, C., Couvreux, D., Vambergue, A., Cazaubiel, M., Fontaine, P., & Subtil, D. (2007) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2007.07.005 · Cited by 19
Optimized Model for Predicting Gestational Diabetes using ML Techniques
Shankar, R. S., Raju, V. V. S., Murthy, K., & Ravibabu, D. (2021) · International Conference on Electronics, Communication and Aerospace Technology (ICECA) · doi:10.1109/iceca52323.2021.9676075 · Cited by 12
“al, [36] have studied Glyburide was used to treat 69 patients with GDM who had failed to respond to dietary treatment.”
MethodOral Antidiabetic Drugs in Pregnancy: The Other Alternative
Langer, O. (2007) · Diabetes Spectrum · doi:10.2337/diaspect.20.2.101 · Cited by 12
Silva, J. C., Heinen, A., Scheidt, M. B., Marcondes, M. A. D. O., & Bertini, A. M. (2007) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032007001100002 · Cited by 12
Predicting failure of glyburide therapy in gestational diabetes
Harper, L. M., Glover, A., Biggio, J., & Tita, A. (2016) · Journal of Perinatology · doi:10.1038/jp.2015.216 · Cited by 13
Homko, C. J., & Trout, K. K. (2006) · Nursing Clinics of North America · doi:10.1016/j.cnur.2006.07.004 · Cited by 14
Prise en charge thérapeutique du diabète gestationnel
Jacqueminet, S., & Jannot-Lamotte, M.-F. (2010) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/s0368-2315(10)70051-x · Cited by 17
“publiée en 2008 [96] rapportait neuf études [97-104], dont une seule randomisée [88], pour un total de 745 femmes traitées par glibenclamide à partir de 24 SA et 637 traitées par insuline.”
BackgroundUsing Oral Agents to Manage Gestational Diabetes: What Have We Learned?
Buschur, E., Brown, F. M., & Wyckoff, J. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0570-5 · Cited by 10
Preditores de sucesso da metformina no tratamento do diabetes mellitus gestacional
Silva, J. C., de Souza, B. V., & Silva, M. R. E. (2013) · Revista Brasileira de Saúde Materno Infantil · doi:10.1590/s1519-38292013000200006 · Cited by 13
Can Pregnant Diabetics be Treated with Glyburide?
Melamed, N., & Yogev, Y. (2009) · Women s Health · doi:10.2217/whe.09.55 · Cited by 9
“Since glyburide is considerably more convenient and less expensive than insulin [51], it is clearly preferred by most patients [47,49], and can thus lead to increased patient compliance.”
BackgroundMethodResultInfluentialResultados preliminares do uso de anti-hiperglicemiantes orais no diabete melito gestacional
Silva, J. C., Taborda, W., Becker, F., Aquim, G., Viese, J., & Bertini, A. M. (2005) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032005000800005 · Cited by 8
Moore, T. R., & Catalano, P. M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4224-2.50049-1 · Cited by 14
Self-citationReview of metformin and glyburide in the management of gestational diabetes
Carroll, D. G., & Kelley, K. W. (2014) · Pharmacy Practice · doi:10.4321/s1886-36552014000400001 · Cited by 8
“Failure rates (requiring management with insulin) in these trials ranged from 6% to 20%.(9,10,12-15) Some limitations of these studies include trial design as well, the small sample size, as well as the lack of diversity in patient populations included (many were exclusively Hispanic populations), and lack of dosing p…”
BackgroundRosenn, B. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903550873 · Cited by 8
“These patients tend to be: older [17]; have had GDM in a previous pregnancy [14]; have had GDM diagnosed at an earlier gestational age [14,17] or following a GCT result above 200 mg/dL [10]; have higher fasting glucose values [1,14,17] or higher mean glucose values on diet [14].”
BackgroundGender-Specific Care of Diabetes
Szalat, A., & Raz, I. (2007) · Women s Health · doi:10.2217/17455057.3.6.735 · Cited by 8
“Glyburide is an oral sulfonylurea hypoglycemic agent that does not cross the placenta and has no known teratogenicity; its use in pregnancy achieved good glycemic control, similar to that obtained under insulinotherapy and without difference in rates of any complication [160,170,217–220].”
BackgroundMobin, A., Obeid, A., El‐Kebbi, I. M., Everett, D., Ibrahim, S. M., Farhat, J., & Al‐Omari, B. (2024) · Chronic Diseases and Translational Medicine · doi:10.1002/cdt3.153 · Cited by 8
Gestational Diabetes Mellitus: Challenges in Diagnosis and Management
Roy, P., Agrawal, P. K., Garg, R., Gautam, A., Hokabaj, S., & Goel, H. (2018) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1558 · Cited by 7
Diabetes Mellitus Complicating Pregnancy
Landon, M. B., Catalano, P. M., & Gabbe, S. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00040-8 · Cited by 7
Traitement du diabète gestationnel par hypoglycémiants oraux
Carles, G., Germain, L., Alassas, N., Guindi, W. E., Dallah, F., & Daigre, J.-L. (2010) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2009.12.002 · Cited by 9
“[13] 2004 69 Prospective Glyburide 81,2 % d’efficacité Jacobson et al.”
Metformin in pregnancy: ready or not?
Homko, C. J., & Reece, E. A. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000216968.82245.bb · Cited by 3
Pharmacological therapy in gestational diabetes – a comparison between insulin and oral therapy
Shmuel, E., Krispin, E., Toledano, Y., Chen, R., Wiznitzer, A., & Hadar, E. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1875208 · Cited by 7
Odiba, J. O., & Mabhala, M. A. (2015) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2015.52007 · Cited by 3
“These findings were inconsistent with the previous observational study conducted by Chmait, Dinise and Moore [19] which showed no statistical differences between these two treatment groups [19].”
ResultAre Oral Hypoglycemic Agents Contraindicated in Pregnancy!
Amin, M. R., Hossain, M. Z., Miah, M. T., Yasmin, R., Chowdhury, M. F. I., & Hoque, M. A. (1970) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v28i2.5376 · Cited by 3
Rao, P. S., Datta, S., & Prajwal, S. (2017) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20171420 · Cited by 2
Antidiabétiques oraux et grossesse
Sénat, M. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30120-7 · Cited by 7
7. Management of hyperglycemia during pregnancy
(2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30015-1 · Cited by 3
Buitrago-Leal, M., & Giraldo, S. M. (2014) · Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud (FUCSALUD) · Cited by 5
Oral antidiabetic agents in gestational diabetes: a narrative review of current evidence
Singh, A. K., & Singh, R. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.982090 · Cited by 2
“Observational studies Kitzmiller et al. (2001) Glibenclamide versus placebo 47 [38] Chmait et al. (2004) Glibenclamide versus insulin 19 [27] Conway et al. (2004) Glibenclamide versus insulin 24 [29] Kremer et al. (2004) Glibenclamide versus placebo 19 [30] Jacobson et al. (2005) Glibenclamide…”
BackgroundInfluential(2008) · Elsevier eBooks · doi:10.1016/b978-032304306-9.50012-4 · Cited by 2
Thompson, D. M., Berger, H. M., Feig, D. S., Gagnon, R. J., Kader, T., Keely, E., Kozak, S. E., Ryan, E. A., Sermer, M., & Vinokuroff, C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.040 · Cited by 8
Case 36-2006: A Pregnant Woman with New Hypertension
Lindheimer, M. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmc063420 · Cited by 2
Oral Anti-diabetic Agents as an Alternative Treatment of Diabetes in Pregnancy
Laila, T. R., & Ahmed, S. S. (2016) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20160402.11
“also showed a satisfactory glucose control in 81% study population [13].”
BackgroundChronic Medical Conditions in Pregnancy
(2008) · Elsevier eBooks · doi:10.1016/b978-032304306-9.50013-6 · Cited by 1
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.036 · Cited by 5
Oral Antidiabetic Agents in Gestational Diabetes Mellitus- Shifting of Paradigm?
Amin, M., Hossain, M., Miah, M., Yasmin, R., Chowdhury, M., & Hoque, M. (1970) · Journal of Dhaka Medical College · doi:10.3329/jdmc.v17i2.6596 · Cited by 1
Oral Hypoglycemic Agents in Pregnancy
Feig, D. S. (2010) · Wiley eBooks · doi:10.1002/9781444315196.ch11 · Cited by 2
Glyburide Is a Safe and Effective Treatment for Gestational Diabetes
Kelly, L. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32733-5 · Cited by 2
Metadata
- Authors
- Chmait, R., Dinise, T., & Moore, T.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Moore, Thomas
- Venue
- Journal of Perinatology
- Published
- 2004-05-20
- Volume
- 24
- Issue
- 10
- Pages
- 617-622
- ISSN
- 0743-8346 (ISSN-L)
- 1476-5543
- OpenAlex
- W1975210351
- Cited by
- 118
- References
- 9
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 5 · 2015: 8 · 2014: 7 · 2013: 10 · 2012: 2
- FWCI
- 10.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Perinatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, glibenclamide, sulfonylurea therapy, treatment failure, predictors of treatment success, fasting blood glucose, postprandial blood glucose, women
- MeSH terms
- Adult, Blood Glucose, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Glyburide, Humans, Predictive Value of Tests, Pregnancy, Pregnancy Outcome, Probability, Prospective Studies, Severity of Illness Index, Diabetes, Gestational, Treatment Outcome, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.